Business

Moltbook claims to be a social network for AI bots. But humans are behind its rapid growth
Trump administration axes $1.5B in blue-state grants over reported waste and mismanagement concerns
Trump administration axes $1.5B in blue-state grants over reported waste and mismanagement concerns
Nearly 1,300 customers affected by Canada Computers data breach, company says
Chrysler recalls more than 450,000 vehicles over brake light failure
Chrysler recalls more than 450,000 vehicles over brake light failure
Major firearms distributor serving thousands of retailers across multiple countries files for bankruptcy
Major firearms distributor serving thousands of retailers across multiple countries files for bankruptcy
Southwest to debut new Super Bowl ad, showcasing its 'self-aware' humor
Southwest to debut new Super Bowl ad, showcasing its 'self-aware' humor
LARRY KUDLOW: For the midterms, it’s still early in the game
LARRY KUDLOW: For the midterms, it’s still early in the game
Senate Banking chair says Powell didn’t commit crime in testimony
Senate Banking chair says Powell didn’t commit crime in testimony
Homebuilders reportedly developing 'Trump homes' program to improve affordability
Homebuilders reportedly developing 'Trump homes' program to improve affordability
Cracker Barrel responds to reports about employee dining requirements during work travel
Cracker Barrel responds to reports about employee dining requirements during work travel
Delta flight abruptly makes midair U-turn after smoke reported from engine
Delta flight abruptly makes midair U-turn after smoke reported from engine
Trans Mountain proceeding with first of three expansions of oil pipeline
Nike’s diversity initiatives under EEOC scrutiny for alleged discrimination against White workers
Nike’s diversity initiatives under EEOC scrutiny for alleged discrimination against White workers
Restored Social Security benefits could get tax break under new bill
Restored Social Security benefits could get tax break under new bill
Moderna CEO hails breakthrough mRNA cancer vaccine that halves melanoma recurrence risk with Keytruda
Moderna CEO hails breakthrough mRNA cancer vaccine that halves melanoma recurrence risk with Keytruda
Desktop versie